Assessment of Symptom and Quality of Life in Pediatric Brain Tumor Survivors
DOI:
https://doi.org/10.37762/jfinph.1Keywords:
Pediatric, Brain Tumo, Survivors, Quality of Life, Symptoms ExperiencesAbstract
OBJECTIVES:
The purpose of this study was to assess the relationship between quality life and demographic variable in pediatric brain tumor survivors.
METHODOLOGY:
A descriptive cross-sectional study was conducted in two tertiary care hospitals of Peshawar, Khyber Pakhtunkhwa. Census method (consecutive) sampling technique was used to collect data from 100 participants using quality of life checklist and symptoms memorial assessment scale.
RESULTS:
The mean age of the participants was 8.71 years. Almost all participants reported symptoms such as: headache, nausea and vomiting, social life restrain, poor schooling, difficulty urination and concentration, poor attention, lack of energy, cough, feeling sadness and nervousness, dry mouth, numbness, difficulty in sleeping, diarrhea, shortness of breath, sweating and itching. Overall, majority (53%) participants had average quality of life, 35% participants had good quality of life, and only 12% participants of the study had poor quality of life.
CONCLUSION:
Pediatric brain tumor survivor patients experienced variety of symptoms. The quality of life among pediatric brain tumor survivor patients was not very bad, as they have reported average quality of life in this study.
References
Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16-27.
Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the US: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2014;11(301):1-18.
Pace A, Villani V, Di Lorenzo C, Guariglia L, Maschio M, Pompili A, et al. Epilepsy in the end-of-life phase in patients with high-grade gliomas. J Neuro-Oncol. 2013;111(1):83-6.
Zhang K, Jian-bo S. A new method for asynchronous multisensor information fusion: 27th Annual German Conference on AI. 2004;70(2):410-23.
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. Cancer J Clin. 2017;67(1):7-30.
Ellison LF, De P, Mery LS, Grundy PE. Canadian cancer statistics at a glance: cancer in children. CMAJ. 2009;180(4):422-4.
Langer CE, Turner MC, Mckean-cowdin R, James L. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev. 2015;23(12):2716-36.
Badar F, Mahmood S. Epidemiology of cancers in Lahore, Pakistan, among children, adolescents and adults, 2010-2012: a cross-sectional study part 2. BMJ Open. 2017;7(12):1-15.
Gupta S, Morris SK, Suraweera W, Aleksandrowicz L, Dikshit R, Jha P. (2016). Childhood cancer mortality in India: direct estimates from a nationally representative survey of childhood deaths. J Global Oncol. 2016;2(6):403-11.
Wilne SH, Dineen RA, Dommett RM, Chu TPC, Walker DA. Identifying brain tumours in children and young adults. BMJ. 2013;347(7928):1-10.
McKinney PA. Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry. 2004;75(suppl_2):ii12–ii17.
Hummel TR, Chow LM, Fouladi M, Franz D. Pharmacotherapeutic management of pediatric gliomas: current and upcoming strategies. Pediatr Drugs. 2013;15(1):29-42.
Hockenberry M. Symptoms management research in children with cancer. J Pediatr Oncol Nurs. 2011;21(3):132-6.
Ruland CM, Hamilton GA, Schjodt-Osmo B. The complexity of symptoms and problems experienced in children with cancer: a review of the literature. J Pain Symptom Manage. 2009;37(3):403-18.
Yeh CH, Wang CH, Chiang YC, Lin L, Chien LC. Assessment of symptoms reported by 10-to 18-year-old cancer patients in Taiwan. J Pain Symptom Manage. 2009;38(5):738-46.
Campbell C, Greenfield JP. Precision oncogenomics in pediatrics: a personal reflection. Mol Case Stud. 2018;4(2):a002865.
Macartney G, Harrison MB, VanDenKerkhof E, Stacey D, McCarthy P. Quality of life and symptoms in pediatric brain tumor survivors: a systematic review. J Pediatr Oncol Nurs. 2014;31(2):65-77.
Ewing JE, King MT, Smith NF. Validation of modified forms of the PedsQL generic core scales and cancer module scales for adolescents and young adults (AYA) with cancer or a blood disorder. Qual Life Res. 2009;18(2):231-44.
MacArtney G, Vandenkerkhof E, Harrison MB, Stacey D. Symptom experience and quality of life in pediatric brain tumor survivors: a cross-sectional study. J Pain Symptom Manage. 2014;48(5):957-67.
Bell KR, O’Dell MW, Barr K, Yablon SA. Rehabilitation of the patient with brain tumor. Arch Phys Med Rehabil. 2007;79(3 SUPPL. 1):37-47.
Pakdaman A. Symptomatic treatment of brain tumor patients with sodium selenite, oxygen and other supportive measures. Biol Trace Elem Res. 2011;62(1–2):1-6.
Abu-Saad Huijer H, Sagherian K, Tamim H. (2013). Quality of life and symptom prevalence as reported by children with cancer in Lebanon. Eur J Oncol Nurs. 2013;17(6):704-10.
Barre PV, Padmaja G, Rana S, Tiamongla. Stress and quality of life in cancer patients: medical and psychological intervention. Indian J Psychol Med. 2018;40:232-8.
